Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Lipton

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|June 11, 2004
Erythropoietin for neurologic protection and diabetic neuropathyStuart A Lipton
Nature Reviews. Drug Discovery|January 21, 2006
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyondStuart A Lipton
Current Opinion in Pharmacology|July 23, 2022
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathwaysStuart A Lipton
Free Radical Biology & Medicine|October 15, 2022
Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's diseaseStuart A Lipton
The European Journal of Neuroscience|January 1, 1992
7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal CulturesStuart A. Lipton
Current Alzheimer Research|June 25, 2005
The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonismStuart A Lipton
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disordersStuart A Lipton
Nature Medicine|April 2, 2004
Sporadic ALS: blame it on the editorStuart A Lipton
Nature|April 2, 2004
Turning down, but not offStuart A Lipton
Nature Neuroscience|March 28, 2008
NMDA receptor activity regulates transcription of antioxidant pathwaysStuart A Lipton
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|June 11, 2004
Erythropoietin for neurologic protection and diabetic neuropathyStuart A Lipton
Nature Reviews. Drug Discovery|January 21, 2006
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyondStuart A Lipton
Current Opinion in Pharmacology|July 23, 2022
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathwaysStuart A Lipton
Free Radical Biology & Medicine|October 15, 2022
Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's diseaseStuart A Lipton
The European Journal of Neuroscience|January 1, 1992
7-Chlorokynurenate Ameliorates Neuronal Injury Mediated by HIV Envelope Protein gp120 in Rodent Retinal CulturesStuart A. Lipton
Current Alzheimer Research|June 25, 2005
The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonismStuart A Lipton
Journal of Alzheimer'S Disease : JAD|January 25, 2005
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disordersStuart A Lipton
Nature Medicine|April 2, 2004
Sporadic ALS: blame it on the editorStuart A Lipton
Nature|April 2, 2004
Turning down, but not offStuart A Lipton
Nature Neuroscience|March 28, 2008
NMDA receptor activity regulates transcription of antioxidant pathwaysStuart A Lipton
Pageof 24